News Type 2 diabetes research: fewer side effects from modified m... Scientists have made progress in the quest to find medication for Type 2 diabetes that causes fewer side effects than current treatments.
News Despite study bust, Vistagen still hopes to file anxiety dru... Vistagen has chalked up another trial failure for fasedienol, its drug candidate for social anxiety disorder.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.